New Delhi, India – 110 016

South Delhi Pharma, New Delhi, India

ENSACOVE (ensartinib) capsules

This specialty medication is authorized and manufactured internationally and is not registered or commercially distributed for retail sale in India. To verify patient eligibility, check international supply availability, or understand the regulatory logistics and documentation process: Call our Compliance Desk at 9891296838 or Email your Inquiry query@southdelhipharma.com.

Ensacove (generic name: ensartinib) is a prescription kinase inhibitor used to treat adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not previously received an ALK inhibitor.

Brand Name: ENSACOVE – On Request
Generic Name: ensartinib
Strength: Capsules: 25 mg and 100 mg of ensartinib
Manufacturer: Xcovery Holdings, Inc.
Approved By: EMA, USFDA
Get access to medicines: In India
Price: On Request

See full prescribing information for ENSACOVE : Patient Information

Is ENSACOVE (ensartinib) officially available/approved in India?

No, as of now, ENSACOVE (ensartinib) is not officially marketed or registered for sale in India. It is mainly accessed in India through a Named Patient Program (NPP), which allows for the legal importation of the medication for patients with a valid prescription from the Registered Medical Practitioner (RMP). For sourcing facilitation services contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or  you can Call/WhatsApp at 9891296838.

Category
Category

Disclaimer: Trademark shown are property of their respective owners and South Delhi Pharma (SDP) India does not lay any claim on them.

Get In Touch

South Delhi Pharma is dedicated to facilitating access to critical, globally approved pharmaceutical therapies tailored to individual patient needs. Established in 1996, It has built a trusted reputation for assisting patients and healthcare institutions in navigating the regulatory frameworks required to securely source high-quality, international life-saving medications.

The SDP is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Query Form

This is an inquiry and facilitation request form. Submission does not constitute a sale, purchase order, or guarantee of medicine availability.

Description

Ensartinib, sold under the brand name Ensacove, is an anti-cancer medication used for the treatment of non-small cell lung cancer. Ensartinib is an anaplastic lymphoma kinase inhibitor used as the salt ensartinib hydrochloride.

The most common adverse reactions include rash, musculoskeletal pain, constipation, cough, pruritis, nausea, edema, pyrexia, and fatigue.

ENSACOVE (ensartinib) capsules, for oral use Initial U.S. Approval: 2024

Contact Sourcing Facilitation Team

Contact Name: Mr. Tarun Garg
Address: 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India)
Mobile/WhatsApp. 9891296838.
Email: support@southdelhipharma.com, southdelhipharma@gmail.com

ENSACOVE (ensartinib) Price in India: Availability & Cost

Availability: ENSACOVE is an internationally manufactured specialty oncology medication. ENSACOVE is not officially registered or commercially available for standard retail sale in India, meaning it does not have a fixed Maximum Retail Price (MRP) in India.

Cost Factors: Imported medicine costs may vary depending on exchange rates, import duties, shipping, dosage and pack size.

For current pricing and availability, patients or caregivers may contact appropriately licensed pharmaceutical importers or authorized sourcing facilitators, subject to applicable Indian regulations and import permissions.

Where Can Patients Access ensartinib (ENSACOVE) in Delhi, India?

Specialty Pharmaceutical Imports & Global Sourcing
South Delhi Pharma (SDP) is a specialty pharmaceutical sourcing and distribution organization headquartered in New Delhi, India, with a delivery coordination network serving major cities and regions across the country.

We support patients, healthcare professionals, hospitals and authorized medical institutions in coordinating access to specialized pharmaceutical products, including oncology medicines and other specialty therapies that may not be readily available through local channels.

Through our international sourcing network and Named Patient Program (NPP) coordination services, SDP assists in facilitating the procurement and delivery process for eligible patients requiring medicines that are not locally marketed or readily available in India, subject to applicable Indian laws, regulatory requirements, import permissions and prescription documentation. Our services are designed to help patients, treating doctors and hospitals navigate the necessary sourcing, documentation and supply coordination processes with an emphasis on regulatory compliance, transparency and patient needs.

Our service coverage includes:

In India, access is facilitated through a legally compliant Named Patient Program (NPP), as per guidelines from the Central Drugs Standard Control Organization. This ensures safe and regulated import of the medicine for individual patients. Brand Name “ENSACOVE” or Generic Name “ensartinib” can be imported for personal use under “Named Patient Program” treatment in in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla India.. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at 9891296838 to get access as per norms.

Our commitment: To support responsible access to specialty medicines through appropriate sourcing channels, subject to applicable regulatory approvals and individual patient eligibility.

Important Disclaimer

ENSACOVE (ensartinib) is a prescription-only medicine and should be used strictly under the supervision of a qualified treating oncologist. All inquiries concerning access or procurement must be supported by a valid medical prescription and relevant patient or healthcare professional documentation, as applicable.

Role of South Delhi Pharma (SDP): South Delhi Pharma acts solely as a pharmaceutical sourcing and facilitation coordination partner. SDP does not manufacture pharmaceutical products. Any procurement, supply or delivery arrangements are subject to the involvement of appropriately authorized entities and compliance with applicable Indian pharmaceutical, drug import, licensing and trade regulations. All facilitation activities are undertaken subject to applicable regulatory requirements, necessary permissions and documentation. Submission of an inquiry does not guarantee product availability, import authorization or procurement.

Required Documents

Required Documentation for Compliance:

To legally purchase and import medicines for patient use in compliance with regulations, authorized suppliers typically require:

  1. A valid, original prescription issued by a registered medical oncologist.
  2. Supporting diagnostic or pathology reports.
  3. Valid patient identification proof and adherence to local personal import and customs guidelines.

How to buy?

How to Buy Imported Medicines in India?

Imported medicines specific cross-border coordination, procurement follows a regulated medical import pathway:

  1. Consultation & Prescription: Secure a formal, valid prescription and medical evaluation from a registered oncologist.
  2. Diagnostic Verification: Provide pathology or genomic test reports.
  3. Connect with Licensed Importers: Contact verified specialty pharmaceutical exporters or Named Patient Program facilitators (such as South Delhi Pharma) that specialize in importing unapproved or overseas-market oncology drugs for legitimate personal patient use.
  4. Customs & Compliance Clearance: Complete the necessary patient identification and import documentation required by Indian regulatory and customs guidelines for personal medical imports.

Related Products